Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 04/26/24
End: 12/28/25
Due: 12/28/26
Phase: N/A
Priority: Normal
Start: 04/25/24
End: 08/23/25
Due: 08/23/26
Phase: N/A
Priority: Normal
Start: 12/31/22
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor | NCT06277804 | Letolab | user2@example.com | None | 2024-03-01 | 2027-07-01 | 2028-07-01 | - | - | 2025-07-14 |
| Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma | NCT06384248 | Letolab | user2@example.com | None | 2024-04-26 | 2025-12-28 | 2026-12-28 | - | - | 2025-07-14 |
| Phase II Clinical Study of LTC004 in Patients With mCRC | NCT06384235 | Letolab | user2@example.com | None | 2024-04-25 | 2025-08-23 | 2026-08-23 | - | - | 2025-07-14 |
| Study of LTC004 in Subjects With Advanced Malignant Tumors | NCT05666635 | Letolab | user2@example.com | None | 2022-12-31 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |